| Accession |
359 |
| Title |
Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML |
| Summary |
To better understand its role in acute myeloid leukemia (AML), we profiled survivin expression in samples obtained from 511 newly diagnosed AML patients and in CD34(+)38(-) AML stem/progenitor cells using a validated reverse-phase protein array |
| Journal |
Blood |
| Publish date |
May, 2012 |
| Corresponding Author |
Bing Z. Carter; Steven M. Kornblau |
| E-mail |
bicarter@mdanderson.org; skornbla@mdanderson.org |
| Array Type |
Reverse phase protein array |
| Species |
Homo sapiens |
| Raw data link |
No relevant experiment link!
|
| Link to PubMed |
PubMed ID:22645176
|
